Skip to content

Clinical trials

Phase 3 Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: Singapore Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20073
20102
20111
20122
20133
20142
20152
20162
20183
20193
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting5
Terminated3
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Exelixis2
Novartis Pharmaceuticals2
Sanofi2
Sumitomo Pharma America, Inc.2
AbbVie1
Abbott1
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms27
Neoplasms by Site7
Carcinoma, Hepatocellular6
Breast Neoplasms5
Digestive System Diseases5
Digestive System Neoplasms5
Neoplasms by Histologic Type5
Adenocarcinoma4
Carcinoma4
Neoplasms, Glandular and Epithelial4

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.